Navigation Links
China Kangtai Cactus Biotech Announces Improved Milk Production in Cows From Company's Cactus Cattle Feed
Date:6/4/2008

Results Expected to Allow Company to Make Key Marketing Claims

HARBIN, China, June 4 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Biotech Inc. (the "Company") (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products in China, announced today test results from studies conducted of cows that received the Company's Cactus Cattle Feed. The studies, which included 30 cows, were conducted in conjunction with the Company's application for a Certificate of National Invention Patent and showed cows that received the Company's Cactus Cattle Feed increased milk production by approximately 15.2% during the twenty-day trial period. In order to be granted the Certificate of National Invention Patent, the applicant is required to demonstrate that its product or invention creates significant value.

The Company also conducted a second test, evaluating the ability of cattle to produce milk under adverse environmental conditions, including cold temperatures and strong wind conditions. The study selected 100 milk cows between the age of 2.5 to 3 years, and divided them into two groups. The cows in the control group were fed with the normal feed which was made by the ranch. The cows in the experimental group received the same feed, but also added 1kg cactus cattle feed to each ton of the normal feed. The milk production of the experimental group increased to 1,372kg from 1,350kg despite the adverse conditions. The milk production of the control group decreased to 1,286kg from 1,380kg. The results suggest that the use of cactus cattle feed additives could increase milk production by 8.44%.

"We are excited by the results of these studies, as it will enhance our ability to market our cactus products, as well as increase the probability that we will be granted important patent protection," said Jinjiang Wang, President of China Kangtai Cactus. "These results further
'/>"/>

SOURCE China Kangtai Cactus Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Pharma Holdings, Inc. Closes $10 Million Financing
2. China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml)
3. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims
4. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
5. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
6. China Pharma Holdings, Inc. Donates Medicine for Sichuan Earthquake Relief
7. China Biologic Products Reports First Quarter 2008 Results
8. China Biologic Products Announces First Quarter 2008 Results Conference Call
9. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
10. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
11. China Sky One Medical, Inc. Changes Management Team
Post Your Comments:
*Name:
*Comment:
*Email: